NCT07197554 2026-02-18A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesSEED Therapeutics, Inc.Phase 1 Recruiting171 enrolled
NCT03842865 2025-06-05Expanded Access of Vigil in Solid TumorsGradalis, Inc.Temporarily not available
NCT01286987 2019-01-10Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsPfizerPhase 1 Completed113 enrolled 39 charts
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled